Xcout Intel
Field Medical, Inc.
Field Medical, Inc. is a clinical-stage medical technology company based in Cardiff-by-the-Sea, California, pioneering innovation in the cardiac ablation market with its second-generation pulsed field ablation therapy system.
Subscribe to see Field Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Field Medical, Inc. at a glance
Field Medical, Inc. is a medical devices company headquartered in United States. Its most recent funding round, Series B, raised $40M in June 2025. Xcout tracks 19 named people at Field Medical, Inc., including Mark A. Turco, MD (President & CEO).
Field Medical, Inc. leadership
- Mark A. Turco, MDPresident & CEO
- Oskar DadasonCFO
- Kit SchneiderChief Strategy Officer
- Steven MickelsenFounder & CTO, Field Medical
- Ben CannonCo-Founder, Cue Growth
- Itzhak FangSenior VP, Technology & Innovation
13 more named people on record for Field Medical, Inc., with roles, board committees and tenure — see the full roster →
Field Medical, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $40M | 2 named | |
| SEC Form D filing | $26.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Field Medical, Inc. competitors
A few of Field Medical, Inc.'s closest competitors — see the full list of competitors and alternatives →
MaxWell Biomedical is a privately held company founded in 2018 and headquartered in San Diego, California. The firm is developing Cardiomodulation, a non-destructive electrical therapy for atrial fibrillation designed to preserve atrial function.
CardiaLen, Inc. is a medical device company formed in 2009 with headquarters in Minneapolis, Minnesota, focusing on the development of novel therapies and electrical stimulation devices for treating atrial and ventricular arrhythmias.
Corfigo develops medical devices for cardiac surgery, specifically the HeartPad XLT Cryoablation System. The system utilizes liquid helium cryothermal energy to ablate diseased cardiac tissue from the heart's outer surface while protecting adjacent structures.
Element Science, Inc. is a U.S. medical-device company developing wearable cardiac-monitoring and defibrillation technologies, including the Jewel Patch wearable cardioverter defibrillator. Its products are intended to serve patients at temporary risk of sudden cardiac death and the clinicians who manage their care.
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
Get Field Medical, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Field Medical, Inc. in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access